Transforming growth factor-␤ (TGF-␤) superfamily members play an important role in growth, differentiation, adhesion, apoptosis, and development in many species from insects and worms to vertebrates. Recently, TGF-␤ signaling has been demonstrated to be negatively regulated by microtubules (MTs), which anchor endogenous Smad2/3 to cytosol and also directly interact with connexin43 (Cx43), and the activity of TGF-␤ is mediated by Cx43. However, the mechanism underlying the intracellular regulation of TGF-␤ activity by Cx43 remains unknown. Here, we found that the functional link between TGF-␤ activation and Cx43 is mediated by interactions among Smad2/3, MTs, and Cx43. We confirmed that Cx43 competes with Smad2/3 for binding to MTs, which Cx43 specifically induces release of Smad2/3 from MTs and increases phospho-Smad2 and which, as a result, Smad2/3 and Smad4 are accumulated in the nucleus, leading to activation of the transcription of target genes. Consistently, knockdown of the endogenous Cx43 activity with doublestrand RNA (dsRNA) in HL1 cardiomyocytes and Cx43 knockout mice cardiomyocytes consistently show the opposite effect. Our findings demonstrate a novel mechanism for Cx43 positive regulation of TGF-␤ function.
INTRODUCTION
Transforming growth factor-␤ (TGF-␤) superfamily members are multifunctional and have been shown to control various developmental and biological responses through transcriptional regulation of diverse genes via receptor-mediated activation of the Smad proteins (Patterson and Padgett, 2000; Attisano and Wrana 2002; ten Djike et al., 2002; Shi and Massagué, 2003) . On binding of secreted TGF-␤ to the type II receptor (T␤RII), type I receptors (T␤RI/ ALK5) are heteromerized and transphosphorylated, resulting in signal transduction through phosphorylation of the receptor-regulated Smads (R-Smads), Smad2 and Smad3. Phospho-Smad2 or phospho-Smad3 then forms a complex with a comediator Smad, i.e., Smad4, which translocates to the nucleus and regulates transcription of target genes .
Connexins (Cx), not only allow direct intercellular communication but also play important roles in regulation of cell proliferation, cell differentiation, and tissue development. For example, it has been shown that the activity of TGF-␤ is mediated by connexin43 (Cx43; Hirschi et al., 2003) . However, the mechanism underlying the intracellular regulation of TGF-␤ activity by Cx43 remains unknown. Furthermore, Cx43 interacts directly with ␤-tubulin, a major component of microtubules (MTs) through its C-terminal tail (Giepmans et al., 2001) . Smad2/3 also binds to ␤-tubulin, which provides a negative regulatory mechanism controlling TGF-␤ activity (Dong et al., 2000; Zhu et al., 2004) . These evidences suggest a possibility that Cx43 is involved in MTs-regulated TGF-␤/ Smad signaling. On the hypothesis that Cx43 regulates TGF-␤ activity by release of Smads from MTs, we sought to identify the molecular mechanism of Cx43 involvement in TGF-␤ signaling. By using biochemical approach and double-strand RNA (dsRNA) knockdown technique in HL1 cardiomyocytes and Cx43 knockout mice cardiomyocytes, we have demonstrated for the first time that Cx43 regulates TGF-␤ activity by triggering the release of Smads from microtubules and serves as a positive regulator in relation to the TGF-␤/Smad signaling pathway.
MATERIALS AND METHODS

Plasmid Constructions
Full-length cDNAs of Smad2 and Smad3 (Remy et al., 2004) provided by S. Michnick (University of Montreal) were inserted into pGEM-3Zf(ϩ) (Promega, Madison, WI) for in vitro translation, plasmid GST-Smad2 (Chou et al., 2003) by A. Moustakas (Ludwig Institute for Cancer Research), plasmids GST-Smad2MH1 and Smad2MH2 (Wrana et al., 1992) by J. L. Wrana (University of Toronto), and plasmids GST-Smad2⌬MH1 and GST-Smad2⌬MH2 by K. Miyazono (University of Tokyo), plasmids GST-Smad3, Smad3NL, Smad3LC, and Smad3C (Zhang et al., 1998) by R. Derynck (University of California at San Francisco), and Smad3N by Y. Zhang (National Cancer Institute, National Institutes of Health), plasmid GFPSmad2 by C. N. Hill (Cancer Research UK London Research Institute) (Nicolas et al., 2004) , and various forms of GST-Cx43 (Giepmans et al., 2001) by B. N. Giepmans (University of California San Diego [UCSD] ). Full-length Cx43 was inserted into pGEM-3Zf(ϩ) for in vitro translation. Full-length cDNA of ␤-tubulin (M␤3; Chang et al., 2005) provided by J. S. Chang (Daejin University) was inserted into pSPUTK (Stratagene, La Jolla, CA) for in vitro translation. Various forms of ␤-tubulin were inserted into pGEX vector (Pharmacia Biotech, Piscataway, NJ).
To generate dsRNA expression plasmids against rat Cx43 and mouse Cx40 and Cx45 mRNAs, the coding regions of Cx43.NT (nt 227-592), Cx43. 593-1118), Cx40.NT (nt 121-609), Cx40.CT (nt 606-1189), Cx45.NT (nt 522-996), and Cx45.CT (nt 997-1633) were constructed by insertion into the pDECAP vector as inverted repeats with a 12-base pair spacer (GGTGCGCATATG). The dsRNA expression plasmids containing the inverted repeat were amplified in Escherichia coli GT116 strain (Invivogen, San Diego, CA), which allows the accurate replication of DNA containing inverted repeats, and purified using the Endofree Plasmid Maxi Kit (Qiagen, Chatsworth, CA). Wild-type Cx43 expression plasmid (pcDNA3.1.Cx43) was constructed as full-length Cx43 cDNA inserted into pcDNA3.1 (Invitrogen, Carlsbad, CA). The tubulinbinding domain (TD) Cx43 mutant (pcDNA3.1.Cx43⌬TD) was constructed by deleting the amino acid residues 234 -243 of pcDNA.3.1.Cx43. For construction of TD expression plasmid (pcDNA.3.1.Cx43JM228-263), the amino acid residues 228-263 were inserted into pcDNA3.1.
GST Pulldown Assays
GST pulldown assays were performed as previously described (Dai et al., 1996) .
Culture of HL-1 Cardiomyocytes
HL-1 cardiomyocytes were obtained from Dr. W. C. Claycomb (Louisiana State University, New Orleans, LA). Cells were cultured on a gelatin (0.02% [wt/vol])/fibronectin (10 g/ml) matrix and were maintained in Claycomb medium (JRH Biosciences, Lenexa, KS) supplemented with 10% (vol/vol) fetal bovine serum (FBS), glutamine (2 mM/l), norepinephrine (0.1 mM/l), penicillin (100 U/ml), and streptomycin (100 U/ml).
Coimmunoprecipitation
For coimmunoprecipitation of endogenous proteins, HL-1 cells were lysed in lysis buffer (50 mM HEPES [pH 7.5], 250 mM NaCl, 0.2 mM EDTA, 10 M NaF, 0.5% NP-40, and cocktail of protease inhibitors). For immunoprecipitation of ␤-tubulin with Cx43 and Smad2/3, lysates were immunoprecipitated using anti-␤-tubulin mAb (TUB 2.1, Sigma), and immune complex was analyzed by Western blotting using anti-Smad2/3 mAb (BD Biosciences, San Jose, CA) or anti-Cx43 antibodies (Sigma, St. Louis, MO) and ECL detection reagents (Amersham). For immunoprecipitation of Cx43 with ␤-tubulin, lysates were immunoprecipitated using anti-Cx43 antibodies, and immune complex was analyzed using anti-␤-tubulin mAb. As negative controls, antiCx40 antibodies (C-20, Santa Cruz Biotechnology, Santa Cruz, CA) and anti-␤-galactosidase mAb (Promega) were used. For anti-phospho-Smad2 analysis, 5 g of pDECAP, pDECAP.Cx43.NT, pDECAP.Cx43.CT, or pDECAP.Cx40.CT together with 1 g of a puromycin-resistant expression plasmid (pact.RM2xINSPuroVer3) was cotransfected into HL-1 cells. At 24 h after transfection, the cells were incubated in puromycin (5 g/ml)-containing Claycomb medium for 3 d. Puromycin-positive cells were harvested and lysed. Lysates were immunoprecipitated using anti-Smad2/3 mAb, and immune complex was analyzed by Western blotting using anti-Smad2/3 mAb or anti-phospho-Smad2 antibodies (Calbiochem).
Luciferase Reporter Assays
Transient transfection of cells was carried out using Lipofectamine (Invitrogen) according to the manufacturer's instructions. For the dsRNA-effected knockdown, HL-1 cells were transfected with 0.5 g of p3TP-lux (or CAGA 12 -Luc), 20 ng of the internal control plasmid pRL-SV, and either 2 g of pDECAP empty vector or distinct Cx-dsRNA expression plasmids, as indicated in the legend for Figure 4A . To examine the effect of Cx43 on TGF-␤ signaling, HL-1 cells were transfected with 0.5 g of p3TP-lux, 20 ng of pRL-SV together with pcDNA3.1.Cx43, pcDNA3.1.Cx43⌬TD, or pcDNA.3.1.Cx43JM228-263 (2 or 4 g). Similar experiments were performed in HeLa cells, with the sole difference being that the reporter vector CAGA 12 -luc was used. For TGF-␤ treatment, TGF-␤1 (PeproTech, Rocky Hill, NJ) was dissolved in 1 mg/4 mM HCl/ml bovine serum albumin. HL-1 or HepG2 cells were transfected with 0.5 g of p3TP-lux, 20 ng of pRL-SV, and 3 g of pDECAP.Cx43.NT, pDECAP.Cx43.CT, or pDECAP.Cx40.CT, which served as a negative control. In addition, HepG2 cells were transfected with 0.5 g of p3TP-lux, 20 ng of pRL-SV, and pcDNA3.1.Cx43 at 0, 1, 3, or 5 g. After transfection, cells were incubated for 32 h in 10% FBS/Claycomb medium or FBS/DMEM, followed by inductions for 8 h with or without 5 ng/ml TGF-␤1. For T␤RI/ALK5 inhibitor treatment, SB-431542 (Tocris, Ballwin, MO) was dissolved in dimethyl sulfoxide (DMSO) and used at a final concentration of 10 M. HL-1 cells were transfected with 20 ng of pRL-SV and the reporter vector CAGA 12 -luc or p3TP-lux (0, 10, 50, 200, or 500 ng) . Similarly to HL-1 cells, HeLa cells were transfected with 0.5 g of CAGA 12 -luc, 20 ng of the internal control plasmid pRL-CMV, and pcDNA3.1.Cx43 at 0, 1, 3, or 5 g. Immediately after transfection, HL-1 or HeLa cells were incubated for 40 h in 10% FBS/Claycomb medium or FBS/DMEM containing either DMSO alone or 10 M SB-431542. For luciferase assays, all samples were harvested together at 40 h after transfection. Luciferase activity in cell lysates was measured using the dual luciferase assay system (Promega) in a Berthold Lumat LB 9705 luminometer (Pforzheim, Germany). The data are expressed as means and SDs (error bars) of a representative experiment performed in triplicate.
Cx43 Mutant Mice
Founder mice (C57BL/6JGjal tm1Kdr ) of uniform genetic background (C57BL/6) were originally purchased from Jackson Laboratories (Bar Harbor, ME). Mice were housed in barrier facilities under standard conditions. All mice were maintained in an inbred background (C57BL/6) so that effects due to genetic variation were minimized. The genotypes of all mice were determined by PCR, using primer sequences and protocols as described (Reaume et al., 1995) . All animal experiments were conducted with the approval of and in accordance with guidelines from the Committee for Animal Research, Kyoto Prefectural University of Medicine.
Primary Cell Culture
Single-cell preparations of fetal cardiomyocytes were isolated from mice deficient for Cx43 (Cx43 Ϫ/Ϫ or Cx43 ϩ/Ϫ ) or wild-type littermates (Cx43 ϩ/ϩ ) and cultured for 48 h in DMEM with 10% FBS. The cardiomyocytes were then used for Smad2/3 and Smad4 immunostaining.
Generation of Cell Line
The HeLa cell line stably expressing GFPSmad2 was generated by transiently transfecting HeLa cells with GFPSmad2 and then selecting transfected cells using 1 mg/ml G418.
Time-Lapse Observations
For time-lapse observations, HeLa cells stably expressing GFPSmad2 were transfected with 1 g of Cx43 expression vector with 10 ng of pcDNA.3.1. mRFP1, which served as a transfectant indicator. After transfection, cells were incubated for 4 h and then imaged under a fluorescence microscope (IX71, Olympus, Tokyo, Japan). Images were taken with a 0.03-s exposure at 30-min intervals with 23 optical sections.
Immunocytochemistry
To express Cx-dsRNAs, 2 g of pDECAP.Cx43.NT, pDECAP.Cx43.CT, pDECAP.Cx40.NT, pDECAP.Cx40.CT, pDECAP.Cx45.NT, or pDECAP. Cx45.CT together with 0.5 g of pcDNA.3.1.mRFP1, which served as a transfectant indicator, was transfected into HL-1 cells. HL-1 and primary cultured cells were rinsed in ice-cold phosphate-buffered saline (PBS) and fixed in 2% paraformaldehyde in PBS for 30 min. After fixation, cells were permeabilized by incubation with 0.1% Triton X-100 in PBS for 10 min. Cells were then blocked with 3% skim milk in PBS for 1 h. Primary antibodies used were anti-Smad2/3 mAb (BD Biosciences; 1:100) and anti-Smad4 mAb (B-8, Santa Cruz; 1:100). Secondary antibodies were used with Alexa Fluor 488 goat anti-mouse IgG (Molecular Probes). Cells were washed carefully with PBS (5 times, 10 min each time) after incubation with primary and secondary antibodies. After immunostaining, samples were mounted and analyzed by confocal microscopy (FV300, Olympus).
RESULTS
Smad2/3 and Cx43 Competitively Bind to the Same Region of ␤-Tubulin
We first examined whether Smad2/3 directly interacts with mouse ␤-tubulin and Cx43 in vitro. The full-length forms of Smad2 and Smad3 were translated in vitro and mixed separately with each of the full-length forms of GST-␤-tubulin and GST-Cx43. Smad2 and Smad3 bound to GST-␤-tubulin but neither to GST-Cx43 nor to the GST resin alone ( Figure  1A ). To investigate which domain of Smad2 interacts with ␤-tubulin, we used a series of deletion mutants of GSTSmad2 in the in vitro binding assay ( Figure 1B ). In vitrotranslated full-length ␤-tubulin was mixed with the various forms of GST-Smad2. The results showed that the MH2 domain of Smad2 binds to ␤-tubulin with almost the same efficiency as the full-length (wild-type) Smad2. Similar results were obtained for the Smad3 binding to ␤-tubulin ( Figure 1C) .
On use of a series of GST-Cx43 proteins containing various portions of the Cx43 molecule, as reported (Giepmans et al., 2001) , the C-terminal juxtamembrane region (GSTCx43JM228-263) bound ␤-tubulin to the same extent as did the full-length GST-Cx43 (Figure 2A) .
To map the region of ␤-tubulin where it interacts with Smad2, we used a series of deletion mutants of GST-␤-tubulin fusion for the GST pulldown assay ( Figure 2B ). The results revealed that the region containing amino acids 114 -243 (GST-␤-tubulin114/243) was required for binding to Smad2 ( Figure 2B ) or Smad3 (data not shown), the same region was also required for binding to Cx43 ( Figure 2B ).
The common binding region of ␤-tubulin for Smad2/3 and Cx43 ( Figure 2B ) indicates that there is competition between Cx43 and Smad2/3 for binding to ␤-tubulin. This possibility was tested by a competition assay ( Figure 2C ). We used in vitro-translated [
35 S]methionine-labeled Smad2 and a dose of cold Cx43 for competitive binding to GST-␤-tubulin114/243. Cx43 interfered with the binding of Smad2 to ␤-tubulin.
Interactions among Cx43, ␤-Tubulin, and Smad2/3 In Vivo We reasoned that Cx43-mediated TGF-␤ signaling could arise from competition between Cx43 and Smad2/3 on MTs.
To examine interactions of MTs with Smad2/3 and Cx43 in vivo, coimmunoprecipitation assays of endogenous proteins were performed with anti-␤-tubulin and anti-Cx43 using lysates prepared from HL-1 cardiomyocytes (Claycomb et al., 1998; White et al., 2004) . Smad2/3 and Cx43 were coprecipitated by anti-␤-tubulin ( Figure 3, A and B) , and ␤-tubulin was coprecipitated by anti-Cx43 ( Figure 3D ). No interaction between Cx40 and ␤-tubulin was detected ( Figure 3C ). Taken together, these results suggest that there are interactions among Cx43 and Smad2/3 at MTs.
Cx43 Positively Regulates TGF-␤ Signaling
In mammalian hearts, myocytes prominently express three major types of connexin proteins: Cx40, Cx43, and Cx45 (van Veen et al., 2001) . To investigate whether Cx43 specifically In vitro-translated ␤-tubulin and various forms of GST-Smad3 were used for GST pulldown assays. Small arrows indicate the protein bands of interest in B and C. The relative binding activities of ␤-tubulin (B and C) are designated ϩ and Ϫ, which indicate 5-10% and Ͻ1% binding of input protein, respectively. The purity and concentration of bacterially expressed GST-fusion proteins were analyzed on 10% SDS-PAGE followed by Coomassie blue staining in B and C.
contributes to TGF-␤ activity in vivo, we examined knockdowns of the endogenous Cx40, Cx43, and Cx45 in cardiomyocytes by producing dsRNA in HL-1 cells using the pDECAP vector (Shinagawa and Ishii, 2003) . Although HL-1 cells predominantly express three types of connexin proteins (Supplementary Figure 1A) , the endogenous mRNAs and the corresponding proteins of Cx40, Cx43, and Cx45 were significantly reduced by respective C-terminal dsRNAs (Supplementary Figure 1, B and C) .
We examined the effect of reducing the amount of the connexin protein on Smad2/3-induced activation of transcription using a luciferase-reporter system in HL-1 cells (p3TP-lux vector; Wrana et al., 1992; Dennler et al., 1998; Stroschein et al., 1999) . Luciferase levels were reduced more than fivefold by cotransfection of p3TP-lux reporter with 1 g of pDECAP vector expressing C-terminal Cx43 dsRNA (pDECAP.Cx43.CT; Figure 4A ). Cotransfection with 1 g of pDECAP vector expressing N-terminal Cx43 dsRNA (pDECAP.Cx43.NT) resulted in reduction by about half. In contrast, cotransfection of 1 g of pDECAP vector expressing dsRNA of Cx40 or Cx45 for the C-or N-terminal region of the gene did not significantly affect the luciferase levels of p3TP-lux reporter. Similar results were obtained in HL-1 cells with the Smad3/Smad4-dependent reporter CAGA 12 -luciferase (Dennler et al., 1998 ; data not shown). These data provide mechanistic evidence that Cx43 expression serves as a positive regulator for TGF-␤ signal transduction.
Next, we reasoned that the subcellular localization of Smads may be affected by the context of Cx43, i.e., whether the Cx43 functions as a positive regulator in relation to the TGF-␤/Smad signaling pathway. To test this possibility, we examined whether decreased Cx43 expression results in reduction of the nuclear accumulation of Smad2/3 and Smad4 specifically. Subcellular localization of Smad2/3 and Smad4 was examined by immunocytochemical analysis of HL-1 cells transfected with the dsRNA expression vector of Cx43 or Cx40. Nuclear accumulation of Smad2/3 and Smad4 was reduced in the Cx43 dsRNA-transfected cells. In contrast to Cx43 dsRNA-expressing cells, no significant difference between the subcellular localizations of Cx40 dsRNA-expressing cells and intact cells was observed ( Figure 4B ). These results demonstrate that even in the absence of the TGF-␤ stimulation, Smad-mediated TGF-␤ signaling is constitutively activated by Cx43 that contributes to the basal level of Smad2/3 and Smad4 in the nucleus.
To test further whether Cx43 specifically regulates TGF-␤ activity among various Cxs via the TD (Giepmans et al., 2001) , we constructed a Cx43 mutant, pcDNA3.1.Cx43⌬TD expression vector, by deleting a potential tubulin-binding motif (amino acids 234 -243) of Cx43, and TD expression vector, pcDNA.3.1.Cx43JM228-263. In the luciferase reporter assays, we initially used HeLa cells, which express no endogenous Cx43 (Lin et al., 2004) . HeLa cells showed a dosedependent increase in TGF-␤-targeted reporter activity when cotransfected with the CAGA 12 -luciferase reporter plasmid together with increasing amounts of wild-type Cx43 or TD expression plasmid Cx43JM228-263 ( Figure 4C ). Overexpression of Cx43 with wild-type Cx43 or TD expression plasmid Cx43JM228-263 at 4 g increased the degree of TGF-␤-targeted reporter transcription to about fourfold even in the absence of TGF-␤. In addition, cotransfection with wild-type Cx43 or TD expression plasmid Cx43JM228-263 in HL-1 cells, which abundantly express endogenous Cx43 (Supplementary Figure 1A) , revealed a similar result, albeit only a slight increase in Cx43-induced TGF-␤-targeted reporter luciferase levels was observed. As expected, when the cells overexpressed Cx43⌬TD expression plasmid, no significant effect on the level of TGF-␤-targeted gene luciferase activity was observed in either HeLa or HL-1 cells ( Figure 4C ). We also examined the effects of Cx43 or Cx43⌬TD on EGF-responsive promoter cyclin D1 (CCND1; Kasper et al., 2006) , no significant effects on the level of EGF-targeted gene luciferase activity was observed by overexpressing either Cx43 or Cx43⌬TD (Supplementary Figure  2) . These findings suggest that the effect of Cx43 on TGF-␤ signaling requires direct binding of Cx43 to MTs via its TD at the C terminus and a resultant release of Smad2/3 from MTs, which consequently readily access T␤RI. Therefore Cx43 may serve as a positive regulator in relation to the TGF-␤/Smad signaling pathway.
Cx43 Is Required for Smad Nuclear Translocation
To further test whether TGF-␤ activity is affected by the expression levels of Cx43 in vivo, we examined the subcellular localization of Smad2/3 and Smad4 in primary cultured cardiomyocytes derived from the hearts of E16 mouse littermates wild-type (Cx43 ϩ/ϩ ), heterozygous (Cx43 ϩ/Ϫ ), or homozygous (Cx43 Ϫ/Ϫ ) for Cx43 ( Figure 5, A and B) . In Cx43 ϩ/ϩ cells, abundant nuclear localization of Smad2/3 and Smad4 was observed. Intermediate nuclear localization of these proteins was detected in Cx43 ϩ/Ϫ cells. In Cx43
Ϫ/Ϫ cells, Smad2/3 or Smad4 was localized uniformly throughout the cells, i.e., it was indistinguishable from the cytoplasm and nucleus. We also examined the effects of TGF-␤ on subcellular localization of Smad2/3 by using primary cultured Cx43 Ϫ/Ϫ cardiomyocytes. TGF-␤ stimulation did not affect the subcellular localization of Smad2/3 (Supplementary Figure 3 ). Moreover, we examined the effects of TGF-␤ on the protein level and subcellular localization of Cx43 by using Cx43 ϩ/ϩ or Cx43 ϩ/Ϫ cardiomyocytes. TGF-␤ stimulation affected neither the protein level nor the subcellular localization of Cx43 (Supplementary Figure 4) .
To further clarify the subcellular distribution of Smad2/3 controlled by Cx43 expression, we generated a HeLa cell line stably expressing GFPSmad2. The subcellular distribution of Smad2 was examined by time-lapse observations of GFPSmad2-expressing HeLa cells transfected with the Cx43 expression vector. GFPSmad2 localization was predominantly cytoplasmic in cells not transfected with Cx43 and predominantly nuclear after 15 h in cells transiently expressing Cx43 (Figure 6 and Supplementary Movie).
Thus, these results suggest that TGF-␤ activity depends on Cx43 expression levels, which control the subcellular localization of Smads.
Cx43 Cooperatively Interacts with TGF-␤ in Regulating TGF-␤/Smad Signaling
To examine whether the expression levels of Cx43 affect TGF-␤-induced activation, we initially cotransfected HL-1 cells with the TGF-␤-targeted reporter together with Cx43 dsRNA or Cx40 dsRNA expression plasmid with or without TGF-␤ stimulation ( Figure 7A ). TGF-␤-induced an increase in targeted reporter luciferase activity. This increase was reduced or completely abrogated by expression of Cx43 dsRNA at basal levels comparable to that in the absence of TGF-␤ stimulation in HL-1 cells. In contrast, Cx40 dsRNA had no significant effect on TGF-␤-induced transcription of the targeted reporter. In addition, cotransfection with the TGF-␤-targeted reporter together with Cx43 dsRNA or Cx40 dsRNA expression plasmid with or without TGF-␤ stimulation in HepG2 cells, which express no endogenous Cx43 (data not shown). As expected, neither Cx43 dsRNA nor Cx40 dsRNA reduced TGF-␤-induced targeted reporter luciferase activity ( Figure 7B ). We also cotransfected HepG2 cells with the TGF-␤-targeted reporter together with Cx43 expression plasmid with or without TGF-␤ stimulation (Figure 7C ). Cx43 cooperatively potentiated the effect in the presence of TGF-␤ on TGF-␤-induced transcription of the targeted reporter. Moreover, a similar result, albeit only a slight increase in TGF-␤-induced targeted reporter luciferase levels was observed in HeLa cells, (Supplementary Figure 5) . These data indicate that Cx43 cooperatively interacts with TGF-␤ in regulating TGF-␤/Smad signaling.
To elucidate whether Cx43-mediated TGF-␤ activity is mediated by continuous stimulation of the TGF-␤ receptors, we used a highly specific and potent T␤RI/ALK5 inhibitor, SB-431542, which instantaneously inhibits ALK5 kinase ac- 
CT). (B)
Cx43 is specifically required for nuclear translocation of Smad2/3 and Smad4 in cardiomyocytes. HL-1 cells were transfected with pDECAP.Cx43.CT, pDECAP.Cx43.NT, and pDECAP.Cx40.CT together with a transfectant indicator, pcDNA.3.1.mRFP1. Cells were fixed and stained with anti-Smad2/3 (left) or anti-Smad4 (right) monoclonal antibodies followed by Alexa Fluor 488 goat anti-mouse IgG and were examined by confocal fluorescence microscopy. (C) The TD of Cx43 is required for Smad-induced transcriptional activity. HL-1 cells (left) were transfected with the reporter vector p3TP-lux and internal control plasmid pRL-SV together with pcDNA3.1.Cx43, pcDNA3.1.Cx43⌬TD, or pcDNA3.1.Cx43JM228-263. HeLa cells (right) were transfected with the reporter vector CAGA 12 -luc, internal control plasmid pRL-CMV, and together with pcDNA3.1.Cx43, pcDNA3.1.Cx43⌬TD, or pcDNA3.1.Cx43JM228-263. All samples were harvested together at the 40-h time point, and luciferase activity was measured and normalized. The data shown in A and C are means and SDs (error bars) of a representative experiment performed in triplicate and were evaluated for statistical significance with two-tailed Student's test. *p Ͻ 0.01; **p Ͻ 0.005.
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Vol. 18, June 2007tivity (Inman et al. 2002a,b; Laping et al., 2002) . HL-1 cells transfected with either p3TP-lux or CAGA 12 -luciferase reporter plasmid were treated with or without SB-431542 for 40 h before reporter assays. A significant inhibition of luciferase reporter transcription was observed in the presence of SB-431542. In contrast, treatment with DMSO produced no remarkable effect on TGF-␤-targeted reporter activity (Figure 7D) . Concomitantly, we observed similar inhibitory effects of SB-431542 on Cx43-induced TGF-␤-targeted reporter activity after cotransfection of HeLa cells with pcDNA3.1.Cx43 together with CAGA 12 -luciferase reporter. Under treatment with SB-431542, Cx43-induced TGF-␤-targeted reporter activity was abrogated ( Figure 7E ). Taken together, these data suggest that Cx43-mediated TGF-␤ signaling acts via type I receptor, T␤RI/ALK5, and phosphorylates Smad2 and Smad3 that form complexes with Smad4, which accumulate in the nucleus and directly regulate transcription of target genes.
Cx43 Regulates TGF-␤/Smad Signaling via the Phosphorylation of Smad2
TGF-␤ signal transduction involves phosphorylation of serine residues located at the C termini of Smad2 and Smad3 by the activated T␤RI (Abdollah et al., 1997; Souchelnytskyi et al., 1997) . To determine whether the Cx43-mediated TGF-␤ transcriptional activity is accompanied by a change in the phosphorylation state of Smad2, we performed Western blotting analysis using a phospho-Smad2-specific antibody (Dong et al., 2000) . We used similar total levels of endogenous Smad2/3 proteins extracted from intact HL-1 cells (untransfected) and HL-1 cells transfected with empty vector pDECAP, dsRNA expression plasmid of Cx43 or Cx40 ( Figure 8A ). In untransfected intact HL-1 cells, a high level of phospho-Smad2 was detected, even in the absence of TGF-␤ stimulation. Although Smad2 phosphorylation was not markedly altered by transfection with empty vector or Cx40 dsRNA expression plasmid, transfection with Cx43 dsRNA expression plasmid remarkably reduced phosphorylation of Smad2 ( Figure 8A ). These data provide mechanistic evidence that intact Cx43 expression may serve as a cytoplasmic regulator for Smad2, mediating Smad2 access to and phosphorylation by T␤RI. Thus, Cx43 functions as a positive regulator of TGF-␤ signaling affecting transcription of TGF-␤/Smad target genes.
DISCUSSION
Nuclear accumulation of Smad2, Smad3, and Smad4 transcription factors is a key event heralding the effective initiation and maintenance of the TGF-␤ signaling pathway . TGF-␤ has pivotal and reciprocal roles in normal and pathological developmental-homeostatic processes (Shi and Massagué, 2003) , and gap junction protein Cx43 has been shown to mediate TGF-␤ activity (Hirschi et al., 2003) . However, the detailed molecular mechanisms by which these activities control TGF-␤ signaling are not clear. Our results for the first time suggest a simple mechanism by which the translocation of Smad2/3 and Smad4 from the cytoplasm to the nucleus is mediated by Cx43 competition with Smad2/3 for binding to MTs ( Figure 8B ). We found that the Cx43 binding to MTs induces TGF-␤ signaling through interference with Smad2/3 binding to MTs at the same region named the "tubulin signature motif" (GGGTGSG). Interference by Cx43 induces release of Smad2/3 from MTs, facilitating the association of Smad2/3 with the receptor kinase T␤RI and subsequent phosphorylation/activation of Smad2/3, leading to translocation of phosphorylated Smad2/3 with Smad4 to the nucleus. Thus, Cx43 may affect the basal level of R-Smads in the nucleus by competitive R-Smads binding to MTs.
To date, TGF-␤ signaling in endothelial cells has been shown to occur via two pathways, the classical pathway involving type I receptor, T␤RI/ALK-5 and phosphorylation of Smad2/3, and another pathway involving ALK-1 for transduction of signals and phosphorylation of Smad1 or Smad5 (Macias-Silva et al., 1998; Chen and Massagué, 1999; Oh et al., 2000) . In the present study, Cx43 was shown to regulate TGF-␤ activity by triggering the release of Smad2/3 from MTs and increase the amount of phosphor-Smad2, with resulting Smad2/3 and Smad4 accumulation in the nucleus ( Figures 2C, 5, 6 , and 8A and Supplementary Movie). It is likely that Cx43-mediated TGF-␤ signaling occurs via the classical pathway.
TGF-␤ stimulation did not affect the subcellular localization of Smad2/3 in primary cultured Cx43 Ϫ/Ϫ cardiomyocytes (Supplementary Figure 3) . Moreover, TGF-␤-induced transcriptional activity was abolished by knockdown of the endogenous Cx43 activity with Cx43 dsRNA at basal levels comparable to that in the absence of TGF-␤ stimulation in HL-1 cells ( Figure 7A ). These results suggest that in the nondividing, terminally differentiated cardiomyocytes, which express abundant endogenous Cx43, Cx43 contribution to Smad transcriptional activity mainly depends on Cx43 expression and not on TGF-␤ stimulation.
Recent genetic studies suggest that Cx43 expression is essential for normal heart formation and function. Homozygous Cx43 knockout mice die neonatally from cono-truncal heart malformation and right ventricular outflow obstruction (Reaume et al., 1995; Waldo et al., 1999) . Moreover, Cx gene products have come to be regarded as tumor suppressors, in that loss of intercellular communication frequently results in transformed cells, whereas restoration of coupling by transfection with Cx genes may serve to slow cell growth (Mehta et al., 1991; Hotz-Wagenblatt and Shalloway, 1993) . Cx43 expression is important for the maintenance of lung homeostasis, and Cx43 ϩ/Ϫ mice show a greater susceptibility to urethane-induced lung carcinogenesis (Avanzo et al., 2004) . TGF-␤ signaling is well known to have a negative effect on cell growth, and inactivation of this pathway contributes to tumorigenesis. Tumor-driven mutations have been observed in both TGF-␤ family receptors and the Smad proteins (Massagué et al., 2000) . The present study for the first time demonstrates that Cx43 specifically regulates endogenous Smad2/3 and Smad4 nuclear translocation without TGF-␤ stimulation. The capacity of Cx43 to positively mediate TGF-␤ signaling suggests a novel mechanism through which Cx gene products may regulate cell growth in a manner quite distinct from their channel-forming properties. HL-1 cells were transfected with a puromycin-resistant expression plasmid (pact.RM2xINSPuroVer3), which served as a resistant transfectant, and the empty vector pDECAP, pDECAP.Cx43.NT pDECAP.Cx43.CT, or pDECAP.Cx40.CT. The cells were incubated with puromycin-containing Claycomb medium (puromycin, 5 g/ml) for 3 d. TGF-␤ stimulation was performed as that HL1 cells were by inductions for 8 h with or without 5 ng/ml TGF-␤1. Lysates of puromycin-positive cells were immunoprecipitated using anti-Smad2/3 mAb. Immune complex was analyzed by Western blotting using anti-Smad2/3 mAb (top), and then the same blotting membrane was analyzed by using antiphospho-Smad2 antibodies (bottom). (B) A proposed model for the role of Cx43 in TGF-␤ signaling.
